Table 2 Acceptability of self-testing for SARS-CoV-2
Female n = 184 (44.12%) | Male n = 233 (55.87%) | P-value | Total n = 417 (100.00%) | |
|---|---|---|---|---|
Awareness of self-testing devicesa | 0.0229 | |||
SARS-CoV-2 | 40 (21.74) | 31 (13.30) | 71 (17.03) | |
HIV | 2 (1.09) | 0 (0.00) | 2 (0.48) | |
HCV | 1 (0.54) | 0 (0.00) | 1 (0.24) | |
Hypertension | 14 (7.61) | 20 (8.58) | 34 (8.15) | |
Pregnancy | 48 (26.09) | 68 (29.18) | 116 (27.82) | |
Diabetes/glycaemia | 149 (80.98) | 178 (76.39) | 327 (78.42) | |
Agreement with the concept of SARS-CoV-2 self-testa | 136 (73.91) | 140 (60.09) | 0.003 | 276 (66.19) |
Willingness to pay | 139 (75.54) | 150 (64.38) | 0.014 | 289 (69.30) |
Amount, USD (mean, SD) | 5.64 USD (SD 4.35) | 5.63 USD (SD 5.06) | 0.99 | 5.64 USD (SD 4.73) |
Likelihood of using a self-testa | 0.596 | |||
Very unlikely | 67 (36.41) | 63 (27.04) | 130 (31.18) | |
Unlikely | 14 (7.61) | 37 (15.88) | 51 (12.23) | |
Neutral | 11 (5.98) | 20 (8.58) | 31 (7.43) | |
Likely | 67 (36.41) | 84(36.05) | 151 (36.21) | |
Very likely | 25 (13.59) | 29 (12.45) | 54 (12.95) | |